During the past decade, Synexus Czech s.r.o. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Synexus Czech s.r.o." are "Atopic Dermatitis" (2 trials), "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "Synexus Czech s.r.o." in a lesser frequency.

Most popular intervention types in "Synexus Czech s.r.o." are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Guselkumab Dose 1" (3 trials), "Guselkumab Dose 2" (3 trials), "Guselkumab Dose 3" (3 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Czech s.r.o." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Synexus Czech s.r.o.". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Synexus Czech s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Czech s.r.o., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".